Statewide quality improvement project reduced excessive radiation treatments for bone metastases by 80%

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.

10:19 PM

Author | Ian Demsky

doctor in white coat scanning person in machine with words "lab note" written on yellow badge with blue font bottom right
Michigan Medicine

An effort by the Michigan Radiation Oncology Quality Consortium reduced excessive radiation treatments for bone metastases by 80% at health care centers across the state, according to findings published in Practical Radiation Oncology.

The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients' bones. Once a standard practice, the American Society for Radiation Oncology has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.

"The goal was to save medical resources as well as reduce the burden on patients," said study first author Elizabeth Jaworski, M.D., a house officer in the Department of Radiation Oncology at U-M. "Patients and their loved ones may have to miss work to get these treatments. There may be travel costs, parking costs — it all adds up. And studies have found that getting more treatments isn't likely to lower their cancer pain any better."

The Michigan Radiation Oncology Quality Consortium, a collaborative quality initiative funded by Blue Cross Blue Shield of Michigan and the Blue Care Network, made a push across its member sites to reduce the procedures in 2018. By the fall of 2020, the use of extended-fraction for bone metastases fell from nearly 15% to just over 3% at 28 radiation facilities across the state.

More extended treatment was likely to happen at non-teaching hospitals and among physicians who had been practicing longer, the study of more than 1,400 patients found.

"We were very pleased to see this effort have such an impact in Michigan. In some parts of the country, use is still higher than 15%," said senior study author James Hayman, M.D., M.B.A., a radiation oncologist at U-M and co-director of the quality consortium. "And, while more than 10 treatments may be appropriate in rare cases, we're continuing to look at ways to reduce the overall number of treatments even further."

Paper cited: "Contemporary practice patterns for palliative radiotherapy of bone metastases: Impact of a quality improvement project on extended fractionation," Practical Radiation Oncology. DOI: 10.1016/j.prro.2021.05.002


More Articles About: Lab Notes Radiation Oncology Cancer Treatment Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories women doc looking ay xray up on bright board
Health Lab
Simple changes in care reduced heart exposure during lung cancer radiation treatment
By raising awareness about the correlation between increased radiation exposure and cardiac events, average doses were reduced without minimizing cancer treatment. 
Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Father’s cancerous brain tumor found weeks after the birth of his daughter
Father’s cancerous brain tumor found weeks after the birth of his daughter
Spilled pills next to a stethoscope and pile of cash
Health Lab
Drug pricing program improved prostate cancer treatment adherence
Socially vulnerable patients were more likely to stick with oral medications when treated at a hospital participating in 340B program, suggesting these hospitals may have more resources to help patients.
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.